0.68 - 0.75
0.33 - 0.86
12.91M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-13.14%
Negative revenue growth while 3606.HK stands at 13.46%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.81%
Negative gross profit growth while 3606.HK is at 13.81%. Joel Greenblatt would examine cost competitiveness or demand decline.
0.61%
Positive EBIT growth while 3606.HK is negative. John Neff might see a substantial edge in operational management.
0.61%
Operating income growth under 50% of 3606.HK's 14.02%. Michael Burry would be concerned about deeper cost or sales issues.
27.53%
Net income growth at 75-90% of 3606.HK's 32.72%. Bill Ackman would press for improvements to catch or surpass competitor performance.
-44.39%
Negative EPS growth while 3606.HK is at 33.33%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
3.34%
Diluted EPS growth under 50% of 3606.HK's 33.33%. Michael Burry would worry about an eroding competitive position or excessive dilution.
129.62%
Slight or no buybacks while 3606.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
23.43%
Diluted share change of 23.43% while 3606.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
114.48%
OCF growth above 1.5x 3606.HK's 18.99%. David Dodd would confirm a clear edge in underlying cash generation.
79.98%
FCF growth under 50% of 3606.HK's 405.73%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
31.83%
10Y revenue/share CAGR under 50% of 3606.HK's 194.23%. Michael Burry would suspect a lasting competitive disadvantage.
-55.08%
Negative 5Y CAGR while 3606.HK stands at 61.56%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-50.53%
Negative 3Y CAGR while 3606.HK stands at 19.94%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
305.97%
OCF/share CAGR of 305.97% while 3606.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-9.31%
Negative 5Y OCF/share CAGR while 3606.HK is at 183.40%. Joel Greenblatt would question the firm’s operational model or cost structure.
-66.91%
Negative 3Y OCF/share CAGR while 3606.HK stands at 140.26%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-34.65%
Negative 10Y net income/share CAGR while 3606.HK is at 220.97%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-33.96%
Negative 5Y net income/share CAGR while 3606.HK is 124.62%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
110.85%
3Y net income/share CAGR above 1.5x 3606.HK's 25.85%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-3.30%
Negative 5Y equity/share growth while 3606.HK is at 123.75%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-32.09%
Negative 3Y equity/share growth while 3606.HK is at 73.94%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 3606.HK stands at 154.16%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-55.41%
Firm’s AR is declining while 3606.HK shows 6.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
83.57%
We show growth while 3606.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-17.48%
Negative asset growth while 3606.HK invests at 3.36%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-51.38%
We have a declining book value while 3606.HK shows 9.13%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-83.12%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-18.82%
Our R&D shrinks while 3606.HK invests at 2.18%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-17.25%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.